Fat tissue study hints at new way to understand aging
NCT ID NCT05989035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collected fat tissue samples from 31 healthy young (18–30) and older (65+) adults. Researchers then tested in the lab how blocking a protein called MetAP2 affects aging-related markers in the fat tissue. The goal was to gather basic knowledge, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new ways to target aging-related changes in fat tissue.
- What could go wrong
- This is a small, early lab-based study in healthy people, not a treatment trial. Results may not lead to any therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AdventHealth Translational Research Institute
Orlando, Florida, 32803, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?
- A handful of walnuts a day: could it keep the aging mind sharp?
- Shining a light on brain aging: could NIR boost memory?